Get the Stockscreener App
13.52
11.29%
-1.72
After Hours:
13.20
-0.32
-2.37%
Ginkgo Bioworks Holdings Inc stock is traded at $13.52, with a volume of 1.76M.
It is down -11.29% in the last 24 hours and up +31.39% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$15.24
Open:
$15.37
24h Volume:
1.76M
Relative Volume:
1.05
Market Cap:
$636.65M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-1.0408
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
-16.23%
1M Performance:
+31.39%
6M Performance:
+85.21%
1Y Performance:
+88.30%
1-Day Range:
$13.50
$15.62
1-Week Range:
$13.50
$17.58
52-Week Range:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
13.52 | 902.20M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Has Ginkgo Bioworks Holdings Inc. found a price floorGlobal Markets & Consistent Profit Trading Strategies - newser.com
Ginkgo Bioworks (NYSE:DNA) Sets New 12-Month HighTime to Buy? - MarketBeat
Will Ginkgo Bioworks Holdings Inc. Class stock benefit from sector leadershipJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock outperform in 2025 bull market2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Custom watchlist performance reports with Ginkgo Bioworks Holdings Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com
Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates - Yahoo Finance
Weiss Ratings Reaffirms Sell (D-) Rating for Ginkgo Bioworks (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Using AI based signals to follow Ginkgo Bioworks Holdings Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Ginkgo Bioworks Holdings Inc. stock chart pattern explained2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Is Ginkgo Bioworks Holdings Inc. still worth holding after the dipJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Ginkgo Bioworks (NYSE:DNA) Trading 14.8% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 4.1% Following Insider Selling - MarketBeat
Why Ginkgo Bioworks Holdings Inc. stock could benefit from AI revolutionJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Do Lower Revenue Projections Reveal a Strategic Pivot for Ginkgo Bioworks (DNA)? - Sahm
Will Ginkgo Bioworks Holdings Inc. stock reach Wall Street targetsJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Ginkgo Bioworks (NYSE:DNA) Insider Sells $84,135.00 in Stock - MarketBeat
How to monitor Ginkgo Bioworks Holdings Inc. with trend dashboardsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Shares Climb 45% But Its Business Is Yet to Catch Up - simplywall.st
How Ginkgo Bioworks Holdings Inc. Class stock behaves in tightening cycles2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
Risk vs reward if holding onto Ginkgo Bioworks Holdings Inc.2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Forbes J M & Co. LLP Sells 17,323 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Biochemicals Global Market Report 2026-2036: From ADM and BASF to Startups Like Ginkgo Bioworks: Biochemicals Market to Revolutionize Chemical Industry by 2036 - Yahoo Finance
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 7.2%What's Next? - MarketBeat
Ginkgo Bioworks Holdings Inc Stock Analysis and ForecastMonthly Performance Summary & Minimal Capital Trading - earlytimes.in
What analysts say about Ginkgo Bioworks Holdings Inc stockIndustrial Stocks Review & Exceptional Growth Investment - earlytimes.in
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ginkgo Bioworks Holdings Inc Stock (DNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Coen Steven P. | See remarks |
Oct 01 '25 |
Sale |
15.00 |
5,609 |
84,135 |
5,503 |
| HENRY CHRISTIAN O | Director |
Sep 09 '25 |
Sale |
11.06 |
10,000 |
110,600 |
24,310 |
| HENRY CHRISTIAN O | Director |
Sep 08 '25 |
Sale |
10.92 |
10,000 |
109,200 |
34,310 |
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):